Amyloids are highly organized cross–β-sheet–rich protein or peptide aggregates that are
associated with pathological conditions including Alzheimer’s disease and type II diabetes. …

We describe a recently recognized disease entity, limbic-predominant age-related TDP-43
encephalopathy (LATE). LATE neuropathological change (LATE-NC) is defined by a …

Neurofibrillary tangles (NFTs) are composed of abnormal aggregates of the cytoskeletal
protein tau. Together with amyloid β (Aβ) plaques and neuronal and synaptic loss, NFTs …

Objective: A randomized, placebo-controlled, double-blind, multicenter 52-week phase 2
trial of resveratrol in individuals with mild to moderate Alzheimer disease (AD) examined its …

Background Treatment of mild-moderate Alzheimer’s disease (AD) subjects (N = 119) for 52
weeks with the SIRT1 activator resveratrol (up to 1 g by mouth twice daily) attenuates …

Noncoding genetic variation is a major driver of phenotypic diversity, but functional interpretation
is challenging. To better understand common genetic variation associated with brain …

Innate immunity is associated with Alzheimer’s disease 1 , but the influence of immune
activation on the production of amyloid-β is unknown 2 , 3 . Here we identify interferon-induced …

Background The cerebrospinal fluid (CSF) biomarkers amyloid β (Aβ)‐42, total‐tau (T‐tau),
and phosphorylated‐tau (P‐tau) demonstrate good diagnostic accuracy for Alzheimer's …

Importance Insulin modulates aspects of brain function relevant to Alzheimer disease and
can be delivered to the brain using intranasal devices. To date, the use of intranasal insulin to …

Histochemical and axonal transport methods were used to clarify the central organization of
cells and fibers that express urocortin (UCN), a recently discovered corticotropin‐releasing …